Clean Harbors Unveils 2027 Growth Targets Amidst Planned Management Transition

Clean Harbors Inc (NYSE:CLH) has unveiled its five-year financial targets, called “Vison 2027.” Based on the organic growth only model,…
  • Clean Harbors Inc (NYSE:CLH) has unveiled its five-year financial targets, called “Vison 2027.”
  • Based on the organic growth only model, the company expects 2027 Adjusted EBITDA of ~$1.4 billion and adjusted free cash flow of ~$600 million.
  • With a model combining both organic growth and acquisitions, the company expects to generate 2027 Adjusted EBITDA of about $2.0 billion and adjusted free cash flow of about $800 million.
  • “Vision 2027 is our plan for building on our track record of growth and sustainability through a continued focus on value creation across all areas of our business,” said co-CEO Eric Gerstenberg.
  • The company assumes expected revenue growth that is 100-300 basis points above U.S. GDP. and expected adjusted EBITDA growth that is 200-300 basis points above revenue growth.
  • As previously announced, as part of a planned transition, on March 31, 2023, Clean Harbors founder Alan McKim will step down as President and CEO to become the company’s Executive Chairman and Chief Technology Officer.
  • Price Action: CLH shares are trading higher by 0.99% at $134.32 on the last check Wednesday.
Total
0
Shares
Related Posts
Read More

EXCLUSIVE: Alzamend Neuro Submits IND For Phase IIA Trial Of Next-Gen Lithium Candidate In Major Depressive Disorder

Alzamend Neuro Inc (NASDAQ: ALZN) has submitted an investigational new drug (IND) application to the FDA to initiate AL001-MDD01, a Phase IIA plasma/brain pharmacokinetics clinical study of AL001 for adjunctive treatment of patients with major depressive disorder (MDD).

ALZN